Early variations of immune aging: the EVIA-NL study

• Conditions: systemische veroudering; Aging; Immunoaging; Inflammaging; 10082206; 10027665

• Registration Number: NL-OMON56850
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

- Aged between 18 and 60 years;
- Able to communicate orally in Dutch or English;
- Able to give informed consent.

Exclusion Criteria

- Any systemic disease or condition, or the use of systemic medication, with
the exception of the following:
o Cardiovascular disease and related medication
o Metabolic syndrome, including diabetes, hypertension, and hyperuricemia
- Pregnancy at inclusion (will be recorded during study);
- Acute illness or fever <1 month before inclusion;
- Received vaccines or antibiotics 3 months before inclusion;
- Participation in an intervention trial;
- Legally incapacitated or unwilling to provide informed consent.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>We refer to the protocol, sections 2 and 5</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N/A</p><br>